For the Quarter Ending December 2025
North America
•In the USA, the Magnesium Stearate Price Index rose by 0.47% quarter-over-quarter, supported by procurement.
•The average Magnesium Stearate price for the quarter was approximately USD 2435.33/MT, reflecting trade averages.
•Magnesium Stearate Spot Price softened in December as competitive import offers pressured domestic replacement bids.
•Magnesium Stearate Price Forecast indicates sideways to slightly negative near-term movement pending post-holiday restocking pace.
•Magnesium Stearate Production Cost Trend stayed flat as stearic acid eased, limiting supplier price increases.
•Magnesium Stearate Demand Outlook remained neutral with pharmaceutical and nutraceutical destocking reducing spot buying urgency.
•Magnesium Stearate Price Index reflected moderate inventory draws, steady import flows preventing sharp CFR volatility.
•Exporters from India and China offered competitive volumes while smooth freight supported timely Gulf arrivals.
Why did the price of Magnesium Stearate change in December 2025 in North America?
•Ample December imports from India and China increased availability, reducing replacement cost pressure for U.S. buyers.
•Stable stearic acid costs provided limited input inflation, constraining producers' incentive to raise magnesium stearate offers.
•Buyers drew down inventories ahead of holidays while smooth logistics reduced urgency, allowing sellers to concede discounts.
APAC
•In China, the Magnesium Stearate Price Index rose by 1.47% quarter-over-quarter, driven by year-end procurement.
•The average Magnesium Stearate price for the quarter was approximately USD 1143.33/MT, per FOB Shenzhen.
•Magnesium Stearate Spot Price was muted as feedstock stearic acid steadied and exporters kept offers.
•Magnesium Stearate Price Forecast indicates modest upside near-term supported by year-end restocking and stable logistics.
•Magnesium Stearate Production Cost Trend subdued as stearic acid eased and energy tariffs remained flat.
•Magnesium Stearate Demand Outlook remains steady with pharmaceutical and nutraceutical procurement sustaining consumption into Q4.
•Magnesium Stearate Price Index volatility was limited by inventories and subdued overseas buying following coverage.
•Chinese exporters trimmed offers into December to clear stock amid seasonal slowdown and global demand
Why did the price of Magnesium Stearate change in December 2025 in APAC?
•Overseas buying softened as India, Vietnam and Germany completed fourth-quarter coverage, reducing immediate export demand.
•Domestic manufacturers entered pre-Lunar-New-Year slowdowns, prompting trimmed procurement and lower spot activity across pharmaceutical formulators.
•Stable stearic acid and flat energy tariffs kept conversion costs steady, enabling producers to trim offers
Europe
•In Europe, the Magnesium Stearate Price Index rose modestly quarter-over-quarter, reflecting year-end pharmaceutical and nutraceutical restocking.
•The average Magnesium Stearate price for the quarter was approximately USD 1,180/MT, based on CFR port assessments at Hamburg, Rotterdam, and Antwerp.
•Magnesium Stearate Spot Prices remained muted as distributors relied on existing inventories and feedstock (stearic acid) costs stayed stable.
•Magnesium Stearate Price Forecast indicated modest near-term upside, supported by incremental restocking and predictable logistics.
•Magnesium Stearate Production Cost Trend remained subdued, with stearic acid prices flat and energy costs stable.
•Magnesium Stearate Demand Outlook stayed steady, underpinned by continued pharmaceutical and nutraceutical procurement.
•Price Index volatility was limited by adequate warehouse coverage and restrained import buying following earlier restocking.
•European formulators maintained cautious spot purchases, relying on inventory cover, while suppliers selectively offered volumes to sustain market activity.
Why did the price of Magnesium Stearate change in December 2025 in Europe?
•Year-end restocking by pharmaceutical and nutraceutical manufacturers increased selective buying, providing mild support to the Price Index.
•Stable feedstock (stearic acid) and energy costs kept conversion expenses predictable, allowing suppliers to maintain disciplined offers.
•Adequate inventories at distributors and importers limited aggressive spot procurement, constraining any sharp upward price movement.
For the Quarter Ending September 2025
North America
• In the USA, the Magnesium Stearate Price Index rose by 7.8451% quarter-over-quarter, from inventory tightness.
• The average Magnesium Stearate price for the quarter was approximately USD 2424.00/MT, CFR Texas import basis.
• Magnesium Stearate Spot Price softened in June but rebounded by August as competitive export offers firmed.
• Magnesium Stearate Production Cost Trend turned upward following persistent stearic acid feedstock inflation, squeezing exporter margins.
• Magnesium Stearate Demand Outlook improved as pharmaceutical and nutraceutical restocking intensified, reducing available working inventories rapidly.
• Magnesium Stearate Price Forecast indicates near-term consolidation then modest firmness driven by seasonal procurement and inventory depletion.
• Elevated PMI readings supported the Magnesium Stearate Price Index momentum and increased buyer urgency during August.
Why did the price of Magnesium Stearate change in September 2025 in North America?
• Tightened inventories across downstream sectors drove urgent restocking, translating into stronger importer acceptance of higher export offers.
• Rising stearic acid feedstock costs increased production costs, pressuring exporter offers and elevating landed import prices.
• Smooth logistics prevented further spikes, but robust pharma and nutraceutical demand sustained price momentum in September.
APAC
• In China, the Magnesium Stearate Price Index rose by 6.49% quarter-over-quarter, driven by stearic costs.
• The average Magnesium Stearate price for the quarter was approximately USD 2270.00/MT, reflecting export mixes.
• Exporters constrained volumes which lifted the Magnesium Stearate Spot Price despite stable manufacturing and logistics.
• Near-term Magnesium Stearate Price Forecast suggests cautious upside as inventories normalize and buyers resume restocking.
• Rising stearic acid pushed Magnesium Stearate Production Cost Trend higher, pressuring margins and supplier offers.
• Magnesium Stearate Demand Outlook strengthened from pharmaceuticals and food sectors, prompting replenishment and forward buying.
• Magnesium Stearate Price Index volatility reflected export inquiry spikes, constrained inventories and port logistics efficiency.
• Major producers maintained steady operations, prioritizing contract customers while managing costs and selective export allocations.
Why did the price of Magnesium Stearate change in September 2025 in APAC?
• Higher stearic acid input costs raised production economics, prompting exporters to increase quotations despite stable logistics.
• Tightening pharmaceutical and food sector procurement reduced available export stocks, increasing buying urgency, supporting firmer prices.
• Elevated prior inventories moderated demand, but scheduled restocking and export inquiries pushed the Price Index upward.
Europe
• In Germany and major EU import hubs, the Magnesium Stearate Price Index rose by ~5.8% quarter-over-quarter, driven by higher stearic acid costs and tighter export availability.
• The average Magnesium Stearate price for the quarter was approximately USD 2,300/MT for CFR Rotterdam imports (conservative regional estimate).
• Magnesium Stearate Spot Price firmed as exporters constrained volumes and European formulators accelerated replenishment for pharmaceutical and food applications.
• Near-term Magnesium Stearate Price Forecast suggests cautious upside as inventories normalize and buyers resume routine restocking.
• Magnesium Stearate Production Cost Trend increased following stearic acid inflation, pressuring supplier margins and underpinning firmer offers.
• Magnesium Stearate Demand Outlook strengthened with pharmaceutical contract buying and seasonal food sector procurement supporting sustained offtake.
• Price Index movement reflected export inquiry spikes, selective allocation by suppliers, and efficient Rotterdam/Hamburg logistics that limited delivery delays.
• Major producers maintained steady operations, prioritizing contracted volumes while managing costs and selective export allocations to Europe.
Why did the price of Magnesium Stearate change in September 2025 in Europe?
• Rising stearic acid input costs raised production economics, prompting exporters to lift quotations.
• Constrained export volumes and active pharmaceutical/food sector replenishment reduced available spot stocks, tightening near-term availability and supporting higher prices.
• Efficient port and inland logistics prevented delivery bottlenecks, so the move was primarily demand- and cost-driven rather than logistics-led.
• Efficient Rotterdam/Hamburg port operations and steady inland logistics reduced premium volatility and supported orderly import flows.
• Stable plant run-rates at origins and manageable, but tightened, European stocks allowed consistent shipments, sustaining the Price Index momentum.
Why did the price of Magnesium Oxide change in September 2025 in Europe?
• Seasonal and programmatic feed dsssemand tightened available import volumes, increasing procurement urgency and lifting prices.
• Higher raw-material and energy costs raised production-cost support for exporters, contributing to firmer offers.
• Smooth port operations and steady export shipments meant price moves were driven mainly by demand/inventory dynamics rather than logistical disruption.
For the Quarter Ending June 2025
North America
• The Magnesium Stearate Spot Price averaged USD 2240/MT in June 2025 and reflected a mild Q2 price erosion of 0.67%. The price fluctuation was driven by subdued demand and elevated inventory levels across nutraceutical and personal care segments.
• The Magnesium Stearate Price Forecast was conservative throughout Q2 as importers prioritized inventory liquidation over new procurements amid stagnant end-user offtakes.
• In April 2025, the Price Index saw a sharp decline of 7.11% that was attributed to lower Chinese export offers. This price drop was a result of drop in the prices of Stearic Acid, and reduced US orders due to tariffs.
• May showed slight price stabilization (0.31% uptick) as pharma and food fortification sectors engaged in safety stock procurement and balanced import volumes without triggering speculative demand.
• By June, steady Magnesium Stearate Production Cost Trends in origin markets ensured consistent overseas supply, despite freight rate volatility and demand-side lethargy in US consumption.
• Importers entered Q2 with substantial inventory buffers, allowing for restrained buying strategies and limited spot transactions, keeping the Magnesium Stearate Spot Price within a tight range.
• No logistical disruptions were reported across Q2, with port and inland operations functioning efficiently, mitigating supply-side risk and preventing upward pressure on landed costs.
• Downstream sectors, particularly OTC and wellness-based nutraceuticals, showed no promotional drivers or seasonal push, muting the Magnesium Stearate Demand Outlook.
• Why did the price change in July 2025?
Exporters from key Asian hubs have adjusted their offers modestly to sustain market share but were unable to trigger any meaningful price rebound due to inventory overhang in the US.
Asia-Pacific
• The Magnesium Stearate Spot Price in June averaged USD 2120/MT, marking a marginal Q2 correction of 0.70% due to weak domestic and overseas downstream demand.
• The Magnesium Stearate Price Forecast remained flat-to-bearish across Q2, as both local and international buyers held off from forward orders amid routine offtake patterns.
• In April, falling Stearic Acid prices helped reduce the Magnesium Stearate Production Cost Trend, allowing suppliers to quote competitively despite stable output levels.
• May saw a minor 0.23% dip in the Price Index, shaped by cautious procurement and steady supply pipeline without any urgent restocking cues from foreign buyers.
• Exporters maintained regular shipment schedules with no port congestion or export curbs, ensuring that supply-side stability neutralized any upward pricing impulses.
• Elevated inventory levels by June, due to weak off-take in pharma and personal care segments, reinforced bearish sentiment in spot transactions.
• Despite stable production and feedstock pricing, the lack of seasonal demand surges or global promotional campaigns constrained the Magnesium Stearate Demand Outlook.
• Chinese suppliers avoided speculative pricing and focused on liquidity and inventory rotation, capping price movement within a narrow band throughout the quarter.
• Why did the price change in July 2025?
The demand from health supplement and OTC product formulators abroad remained routine in early July 2025 with no major global events triggering bulk orders.
Europe
• European Magnesium Stearate Spot Prices likely trended slightly downward in Q2 2025, in line with global market sentiment and steady import flow from Asia-based suppliers.
• The Magnesium Stearate Price Forecast for Q2 was shaped by stable production at origin markets and weak seasonal triggers across EU-based pharma and personal care manufacturers.
• April likely saw softening in the Price Index, influenced by lower Asian offers and easing freight rates, especially from Chinese ports to key European entry points.
• Mid-quarter, consistent production cost control and absence of raw material price shocks contributed to a steady Magnesium Stearate Production Cost Trend, which discouraged price hikes.
• European buyers likely mirrored U.S. and APAC procurement behaviour—working through Q1 stockpiles rather than initiating aggressive restocking, keeping demand neutral.
• No reports of supply chain disruptions or port delays suggest that import costs remained under control, helping stabilize regional landed prices.
• Pharmaceutical and cosmetic sector offtake in Europe remained largely contract-based and tied to routine demand, with no visible uptick in Magnesium Stearate Demand Outlook.
• Buyers remained price-sensitive throughout Q2, especially given the strong euro and moderate energy input cost levels across the continent.
• Why did the price change in July 2025?
Export quotations into Europe were stable-to-soft as global suppliers prioritized volume over margins in a tepid demand landscape in July 2025.
For the Quarter Ending March 2025
North America
In the first quarter of 2025 the prices of Magnesium Stearate in North America increased by an average of 11.68% compared to the previous quarter. The rise was mainly supported by improved demand from pharmaceutical and nutraceutical industries. Buyers showed strong interest as seasonal transition from winter to spring brought higher production activities across several sectors. Procurement remained active throughout the quarter.
Inventory levels were carefully managed by suppliers, which helped avoid sudden supply gaps. There were tariff changes during the quarter, but they did not have any significant impact on Magnesium Stearate prices. Supply conditions were smooth, and no major logistic bottlenecks were reported in North American region during first quarter of 2025.
Overall, higher usage in personal care and food-grade applications also supported the upward momentum. The positive sentiment in the domestic market coupled with anticipation of increased downstream production cycles contributed to price firmness. The combination of demand recovery and planned procurement made the first quarter fairly strong for Magnesium Stearate in the North American market.
Asia Pacific
Magnesium Stearate prices in Asia Pacific increased by an average of 7.87% from the previous quarter to the first quarter of 2025. This rise was a result of gradual improvement in demand across pharmaceutical and personal care industries. The increasing demand was supported by seasonal uptick in production activities and steady consumption patterns across end-user markets.
Strategic buying before the Chinese Lunar New Year contributed to the upward push in January. Post-holiday restocking by buyers in February and March kept consumption levels steady. Seasonal transition also played a part, as production in warmer months started picking up pace. Suppliers in key exporting regions maintained tight control over inventories, which limited supply availability at certain points during the quarter. Despite relatively stable costs of raw materials better export momentum helped support the overall price trend for the APAC region. Procurement remained smooth, and logistics faced no major challenges in the region. The general sentiment in the Asia Pacific market reflected healthy demand planning, and buyers remained focused on forward-looking needs. These combined factors led to a firm and gradual price increase for Magnesium Stearate throughout the first quarter of 2025.
Europe
In the first quarter of 2025, the price of Magnesium Stearate in Europe experienced a steady increase, aligning with global market trends. The pharmaceutical, nutraceutical and personal care sectors were key drivers of this rise, as demand in these industries remained strong. Strategic procurement practices and the effective management of inventory levels ensured a continuous supply, helping to avoid any significant supply disruptions.
Additionally, the seasonal transition played a role in maintaining stable demand. As the weather warmed, production activities across several downstream sectors, such as personal care and pharmaceuticals, saw an uptick, which further supported price stability. With an efficient logistics network in place, transportation remained smooth, and deliveries were timely, which contributed to the overall stability of the market.
The price increase can also be attributed to the growing confidence in procurement strategies and the healthy demand from downstream industries. Overall, the European Magnesium Stearate market displayed growth in the first quarter of 2025, in line with trends observed in other regions, indicating a balanced and well-supported market environment.
